Less than 1% of heart failure (HF) patients with reduced ejection fraction are on target doses of all four drug classes within 12 months of an index hospitalization, yet these protocols have been proven to improve symptoms, slow disease progression, reduce costly admissions, and increase life expectancy. This data point must serve as a rallying cry in the nation’s quest to combat heart failure as a leading cause of death.
In this webinar, Dr. John Janas will:
- Review the current HF treatment gaps
- Discuss the latest evidence-based recommendations for changes to guideline-directed medical therapy (GDMT) and key changes to prior CHF guidelines
- Explore the role that technology could play in improving HF care while reducing the burden on care teams
John Janas, MD
Dr. John Janas empowers Twistle by Health Catalyst clients with clinical content and best practices to manage acute and chronic conditions in the home using patient engagement and remote patient monitoring strategies. He applies his 35-plus years of clinical practice experience and 25 years of EMR implementation and content development expertise to help payers, physician groups and value-based care providers improve care management and reduce costs.